Clinical trial / 1993
Ascorbic acid supplementation was associated with reduced symptom severity in autistic children.
A 30-week double-blind, placebo-controlled trial evaluated ascorbic acid (8g/70kg/day) in 18 autistic children in a residential school. Participants were randomly assigned to an ascorbate-ascorbate-placebo or ascorbate-placebo-ascorbate treatment sequence, with each phase lasting 10 weeks. Weekly ratings on the Ritvo-Freeman scale showed significant group by phase interactions for total scores and sensory motor scores, indicating a reduction in symptom severity associated with ascorbic acid treatment.
- Study type
- 30-week double-blind, placebo-controlled randomized crossover trial
- Who was studied
- 18 autistic children in residential treatment
- What was measured
- Behaviors rated weekly using the Ritvo-Freeman scale
THE PAPER
A preliminary trial of ascorbic acid as supplemental therapy for autism.
Dolske MC, Spollen J, McKay S, Lancashire E, Tolbert L. Prog Neuropsychopharmacol Biol Psychiatry, 1993.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.